Playtika Holding Corp. Reports Q1 2024 Financial Results
May 09, 2024 06:36 ET
|
Playtika Holding Corp.
Revenue of $651.2 million and Direct-to-Consumer (“DTC”) Revenue of $171.5 millionDTC Platforms Revenue Increased 6.1% Sequentially and 13.2% Year Over YearGAAP Net Income of $53.0 million and Credit...
Outbrain Announces First Quarter 2024 Results
May 09, 2024 06:30 ET
|
Outbrain Inc.
NEW YORK, May 09, 2024 (GLOBE NEWSWIRE) -- Outbrain Inc. (Nasdaq: OB), a leading technology platform that drives business results by engaging people across the Open Internet, announced today...
Aveanna Healthcare Holdings Announces First Quarter 2024 Financial Results and Revised 2024 Outlook
May 09, 2024 06:30 ET
|
Aveanna Healthcare Holdings, Inc
First Quarter Revenue was $490.7 million, a 5.2% increase over the prior year Gross margin increased 1.0% to $145.9 million, compared to Q1 2023 First Quarter Net loss was $11.2 million, compared to...
Arhaus Announces First Quarter 2024 Financial Results
May 09, 2024 06:30 ET
|
Arhaus, Inc.
ARHAUS ANNOUNCES FIRST QUARTER 2024 FINANCIAL RESULTS
Sotherly Hotels Inc. Reports Financial Results for the First Quarter Ended March 31, 2024
May 09, 2024 06:30 ET
|
Sotherly Hotels Inc.
WILLIAMSBURG, Va., May 09, 2024 (GLOBE NEWSWIRE) -- Sotherly Hotels Inc. (NASDAQ: SOHO), (“Sotherly” or the “Company”), a self-managed and self-administered lodging real estate investment trust (a...
GigaCloud Technology Inc Announces First Quarter Ended March 31, 2024 Financial Results
May 09, 2024 06:30 ET
|
GigaCloud Technology
-- Revenue Nearly Doubled and Hit Record High; Further Accelerated GigaCloud Marketplace Across all Metrics -- EL MONTE, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- GigaCloud...
X4 Pharmaceuticals Announces $125 Million Capital Infusion from $105 Million Sale of Priority Review Voucher and $20 Million Drawdown from Existing Loan Facility
May 09, 2024 06:30 ET
|
X4 Pharmaceuticals
$125 million of non-dilutive capital extends projected cash runway into late 2025, excluding expected commercial sales from XOLREMDI™ (mavorixafor) XOLREMDI, the first drug indicated in patients with...
Liquidity Services Announces Second Quarter Fiscal Year 2024 Financial Results
May 09, 2024 06:30 ET
|
Liquidity Services, Inc.
Market Share Expansion Drives Double Digit Organic GMV Growth and Record Transaction Volumes GAAP Net Income up 35%, Non-GAAP Adjusted EBITDA up 22% BETHESDA, Md., May 09, 2024 (GLOBE NEWSWIRE) --...
Embecta Corp. Reports Second Quarter Fiscal 2024 Financial Results
May 09, 2024 06:30 ET
|
Embecta Corp.
PARSIPPANY, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three and six...
GoHealth Reports First Quarter 2024 Results
May 09, 2024 06:00 ET
|
GoHealth, Inc.
CHICAGO, May 09, 2024 (GLOBE NEWSWIRE) -- GoHealth, Inc. (NASDAQ: GOCO) (“GoHealth” or the “Company”), a leading health insurance marketplace and Medicare-focused digital health company, today...